首页> 外国专利> INTERMEDIATES FOR PREPARING HIV-PROTEASE INHIBITOR NELFINAVIR, PROCESS FOR THEIR PREPARATION AND METHODS OF PREPARING NELFINAVIR

INTERMEDIATES FOR PREPARING HIV-PROTEASE INHIBITOR NELFINAVIR, PROCESS FOR THEIR PREPARATION AND METHODS OF PREPARING NELFINAVIR

机译:制备HIV蛋白酶抑制剂奈非韦的中间体,其制备过程和制备奈非韦的方法

摘要

A compound of the formula wherein R1 is heteroaryl; or a group of the formula wherein R2 is an alkyl group, a cycloalkyl group, a heterocycloalkyl group, or O-R6, wherein R6 is an alkyl group, an aralkyl group, or an aryl group; or R1 is a group of the formula 252 ו' בניסן התשס" ד - March 28, 2004 wherein each R3 is independently an alkyl group, a cycloalkyl group, a heterocycloalkyl group, an aryl group, or a heteroaryl group; or R1 is a group of the formula wherein R4 and each R5 independently are an alkyl group, a cycloalkyl group, a heterocycloalkyl group, an aryl group, or a heteroaryl group; and X is OH; OR7, wherein R7 is alkyl or aryl; halogen; pseudohalogen; OSO2R8, wherein R8 is alkyl or aryl; heteroaryl bonded through the heteroatom; or N-hydroxyheterocylic bonded through the oxygen, with the proviso that when R1 is CH3C(O)-, X cannot be - OH; or a pharmaceutically acceptable salt or solvate thereof.
机译:式中R 1为杂芳基的化合物;或其中R 2为烷基,环烷基,杂环烷基或O-R6的式的基团,其中R6为烷基,芳烷基或芳基;或R1是式252的基团-2004年3月28日,其中每个R3独立地是烷基,环烷基,杂环烷基,芳基或杂芳基;或R1是式中R 4和R 5各自独立地是烷基,环烷基,杂环烷基,芳基或杂芳基的基团; X是OH; OR7,其中R7是烷基或芳基;卤素;假卤素;和OSO2R8,其中R8为烷基或芳基;通过杂原子键合的杂芳基;或通过氧键合的N-羟基杂环基,条件是当R1为CH3C(O)-时,X不能为-OH;或药学上可接受的盐或溶剂化物其。

著录项

  • 公开/公告号IL128567B

    专利类型

  • 公开/公告日2004-03-28

    原文格式PDF

  • 申请/专利权人 AGOURON PHARMACEUTICALS INC.;JAPAN TOBACCO INC.;

    申请/专利号IL128567

  • 发明设计人

    申请日1997-09-04

  • 分类号C07C65/21;C07C69/76;C07C309/63;C07D217/26;C07F7/18;

  • 国家 IL

  • 入库时间 2022-08-21 23:10:40

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号